David Hampton

Biomedical engineering, Cardiology, Clinical Trials, Cognitive science and Emergency Medical Care

Signal processing, clinical decision analysis, narrative parsing, remote patient monitoring

Biomedical signal processing, biomedical feature recognition, medical data visualization.

C and Perl programming, Matlab / Systat / BMDP, Office.

Time series / modelling / simulation analysis Clinical trial statistics; clinical decision / analysis algorithms.

Program management, cCommercialization of innovation.

English (Native); Dutch (Level 2)

David R. Hampton, PhD is an experienced global leader in medical device innovation and new business development, creating profitable new products for diagnostic and informatics markets. Dr. Hampton developed the first commercial quantitative EEG and brainmapping systems for neurology and psychiatry, and later led European and US teams developing interpretive ECG systems for paramedics and technologies to optimize the treatment of cardiac arrest. As an expatriate in the Netherlands, he led Medtronic’s development of subcutaneous monitors for event alerting and was a Fellow at the Bakken Research Center. Most recently, Dr. Hampton founded and secured startup funding for two medical technology companies, CamStent Ltd (UK: Biofilm-resistant medical coatings) and Stone Bridge Biomedical BV (NL: Remote patient monitoring systems). He resides in Maastricht and is a Senior Member of the IEEE, a Fellow of the AIMBE, and a Senior Associate at the University of Cambridge (UK) lecturing in Medical Diagnostics and Devices.

Sailing, travel, reading, writing

University of Cambridge - Medical Devices and Diagnostics

International Society for Computerized ECG (ISCE); IEEE Biomedical Engineering; Computing in Cardiology; European Resuscitation Council, American Heart Association; American Institute for Medical and Biological Engineering.

Journal of Electrocardiology